Mediatech, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mediatech, Inc. - overview
Location
Manassas, VA, US
Primary Industry
Biotechnology
About
Mediatech, Inc. specializes in high-performance culture media and reagents essential for cell culture applications, supporting advancements in life sciences research and development. Mediatech, Inc. focuses on providing critical components for cell culture, enhancing research and development in life sciences.
The company was founded by Santanu Das, who has a background in creating innovative laboratory solutions. Based in Manassas, US, Mediatech was acquired by Corning Inc. in December 2011 for an undisclosed sum. At the time of acquisition, the deal generated 4.
1x Great Point’s capital, or an IRR of approximately 500%. Mediatech offers high-performance culture media, sera, and reagents that are integral to cell culture applications. Their key products include Dulbecco's Modified Eagle's Medium (DMEM), Phosphate Buffered Saline (PBS), and various formulations of Fetal Bovine Serum (FBS), which are widely used across academic institutions, biotechnology companies, and pharmaceutical firms globally. These products cater to essential needs in molecular biology applications, supporting cancer research, cell therapy, and drug discovery across regions including North America, Europe, and Asia.
Mediatech generates revenue primarily through direct sales of its life sciences products in a B2B model. Customers can select and purchase products via an online catalog, allowing for both small and large orders. Major product lines, particularly DMEM and FBS, serve as key revenue drivers, with pricing reflecting a commitment to quality and competitive market positioning. Mediatech aims to expand its product offerings and enhance its market presence.
Although specific new products and their launch dates have not been disclosed, the company is strategically positioned to leverage recent advancements. The funding from the acquisition by Corning Inc. will likely support Mediatech's initiatives to penetrate new markets and geographic regions, although specific targets have not been mentioned. The acquisition deal, completed in December 2011, is expected to provide resources to facilitate these growth plans.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.cellgro.com
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Mediatech, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Mediatech, Inc. | - | ||||||||
| Buyout | Completed | Mediatech, Inc. | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.